GSK ordered to pay Vectura $89.7m in patent damages
07-05-2019
Hikma and Vectura collaborate to develop GSK generics
12-11-2018
Vectura sues GSK for patent infringement
29-07-2016
BrianAJackson / iStockphoto.com
The English High Court has ruled in favour of GSK in its patent dispute with Vectura, a UK-based pharmaceutical company which specialises in inhalable medicaments.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
GSK, Vectura, English High Court, patent infringement, pharmaceuticals, arrow declaration
